110
Participants
Start Date
May 10, 2024
Primary Completion Date
November 30, 2025
Study Completion Date
March 31, 2026
Jatenzo
237 mg JATENZO twice daily
AccuMed Research Associates, Garden City
Rochester Clinical Research, LLC, Rochester
Centennial Medical Group, Columbia
Alliance for Multispecialty Research, Norfolk
Raleigh Medical Group, Raleigh
Velocity Clinical Research, Inc., Durham
Wilmington Health, PLLC, Wilmington
Catawba Valley Medical Group, Inc., Hickory
Piedmont Healthcare, PA, Statesville
Velocity Clinical Research, Savannah
Hillcrest Medical Research, LLC, DeLand
Clinical Research Center of Florida, Pompano Beach
Global Health Clinical Trial Crop, Miami
Reserka LLC, Miami
Renstar Medical Research, Ocala
Clinical Investigation Specialists, Inc., Kenosha
Velocity Clinical Research, Omaha
VAST Clinical Research LLC, Garland
Epic Medical Research LLC, DeSoto
SMS Clinical Research LLC, Mesquite
Velocity Clinical Research, Austin
Alpine Research Organization, Inc., Clinton
Highland Clinical Research, Salt Lake City
Alliance for Multispecialty Research, Tempe
Long Beach Research Institute, LLC, Long Beach
Integrated Clinical Research, Tarzana
Clinical Trials Research, Lincoln
Collaborators (1)
ICON plc
INDUSTRY
Tolmar Inc.
INDUSTRY